# LENVATINIB
> **ANDA213092** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM INDS INC · Approved 2022-03-01
## Drug
- **FDA Application Number:** ANDA213092
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LENVATINIB
- **Generic name:** Lenvatinib Mesylate
- **Active ingredients:** LENVATINIB MESYLATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SUN PHARM INDS INC
- **First approval:** 2022-03-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213092)
---
*AI Analytics · CC0 1.0*